Douglas Peller, DO
Otolaryngology/Facial Plastic Surgery · Thornton, CONPI 1083754600
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $646 and has fallen 63.3% since, to $237 in 2025.
Across 124 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$430
- GSK$405
- Medtronic$389
- Sanofi$329
- Regeneron Healthcare Solutions, Inc.$274
- Aerin Medical Inc.$176
- plus $814 from 18 others
What the payments were for
- Food & beverage$2,62193%
- Other$1977%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 26 | $430 |
| GSK | 22 | $405 |
| Medtronic(2 entities) | 8 | $389 |
| Sanofi | 12 | $329 |
| Regeneron Healthcare Solutions, Inc. | 16 | $274 |
| Aerin Medical Inc. | 7 | $176 |
| Integra Lifesciences Corporation | 3 | $148 |
| Stryker | 5 | $138 |
| Acclarent, Inc | 5 | $97 |
| Olympus America Inc. | 3 | $86 |
| Kls-martin L.p. | 2 | $53 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| Acera Surgical, Inc. | 1 | $34 |
| Kerecis Limited | 1 | $31 |
| Acell, Inc. | 2 | $29 |
| Merck | 1 | $28 |
| Reddress USA, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Convatec Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Bolder Surgical LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BILAYER WOUND MATRIX (BWM)$100
- INTEGRA WOUND MATRIX (IWM)$100
- AMNIOEXCEL$100
- IDRT$100
- FLOWABLE$100
How this compares
Too few otolaryngology/facial plastic surgery providers in Coloradoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucalaMepolizumab | 13 | $48,910 |
| Azelastine Hcl | 88 | $2,585 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $1,792 |
| Fluticasone Propionate | 104 | $1,784 |
| Famotidine | 95 | $1,756 |
| Ofloxacin | 51 | $1,699 |
| Pilocarpine Hcl | 11 | $1,278 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 18 | $945 |
| Cephalexin | 38 | $350 |
| Omeprazole | 23 | $345 |
| Ipratropium Bromide | 19 | $337 |
| Methylprednisolone | 35 | $271 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $231 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $145 |
| Amoxicillin | 32 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala | $405 | $48,91013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few otolaryngology/facial plastic surgery providers in Coloradoon file to place this against a meaningful peer group, so we don't.
Other otolaryngology/facial plastic surgery in Thornton
- Stephen WeberLone Tree$157K
- Jeffrey RavalDenver$4K
- Arlen MeyersDenver$3K
- Nicolette PicernoDenver$3K
- Mark GriffinGrand Junction$3K
- Mark NoelMontrose$2K
- Duane HartshornGrand Junction$2K
- Christopher CoteDenver$1K
- Michael MenachofGreenwood Village$1K
- Justin RossColorado Springs$480
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.